Founded: 2019
Founders: Ronjun Chen, Meimei ZOU
CEO: tbc
The company develops biopolymer-based delivery technology for cell therapies. It holds a patent for the solution to two of the major problems in immunotherapy today. The first is cell preservation. The second is cell modification.
AlphaCells is currently on hold, seeking ways to capitalise on its IP.